OM Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -11.69%, SMA50 -15.13%, SMA200 -69.28%). The stock’s 14-day RSI is 40.69 (neutral), while the ATR of 0.37 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -83.44% below its high and over 17.42% above its low. Average 10-day trading volume of 167.84 thousand shares is below the 3-month average of 195.26 thousand, indicating normal recent market interest.

Outset Medical, Inc. has 18.80 million shares outstanding. The public float is 14.77 million shares, elevated short interest at 8.22% of float. This equals 1.14 million shares. The short ratio is 7.42 days. Institutional investors hold 89.58% of the float. Insiders own 5.07%. Williamson Steven S. holds 320.35 thousand shares, Racine Jean-Olivier has 265.32 thousand shares and Trigg Leslie has 194.60 thousand shares. Over the past six months, insider transactions show net selling. They sold 35.95 thousand shares across 7 transactions.

Outset Medical, Inc. generated EPS of -$6.81 over the past year. Five-year average earnings growth is 28.06%. Wall Street analysts project EPS growth of 25.33% annually over the next five years. The latest quarter delivered EPS of -$0.80. The next quarter is forecast at -$0.75. Next year's EPS is expected at $27.66. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 5 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $17.00 to $14.00. The high target offers 439.68% upside. The low target suggests 344.44% downside. The mean target is $16.00. This offers 407.94% upside. Outset Medical, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 06, 2026, missed forecasts by 11.63%. The prior quarter beat by 5.06%. Over the last six quarters, Apple has recorded several small beats. These include 234.02% in May 07, 2025.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Outset Medical, Inc. (NASDAQ:OM) closed at $3.15 USD, losing -$0.06 (-1.87%) from the previous close of $3.21. The stock is currently within 5% of its 52-week low $3.00 and $16.16. With a market capitalization of about $58.39 million, Outset Medical, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.90). Key stats such as the average daily volume over the past year has been around 195.39 thousand shares, volume is running light vs its 52-week average. Headquartered in San Jose, CA, Outset Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Leslie L. Trigg, the company employs approximately 310 people and listed since September 15, 2020. Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems.

Outset Medical, Inc. trades at a P/E ratio of -0.78, slightly below the S&P 500 average, with a price-to-sales ratio of 0.5 and a price-to-book ratio of 0.61 suggesting the stock is closer to book value. The P/FCF stands at -1.52, also below market averages.

Outset Medical, Inc. (NASDAQ:OM) shares are up 36.12% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Outset Medical, Inc. trading at a premium to the broader market with a P/E of -0.78. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $24.16, suggesting 666.98% upside. Our AI forecast model points to short-term weakness (-20.32% over two weeks), a medium-term fall (-81.9% over three months), and a longer-term loss (-81.9% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Outset Medical, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -20.32%, with price expected at $2.51 by September 28, 2026, within a range of $2.27 to $2.72 3-Month Outlook: Projected fall of -81.9%, reaching $0.57 by December 11, 2026, with a range of $0.20 to $0.94. 1-Year Outlook: Projected loss of -81.9%, with price at $0.57 by September 14, 2027, within a range of $0.00 to $0.00.